Paul G Barnett1, Adam Chow2, Nicole E Flores2, Scott E Sherman3, Sonia A Duffy4. 1. VA Health Economics Resource Center, Menlo Park, California; VA Center for Innovation to Implementation, Menlo Park, California; Department of Health Research Policy, Stanford University School of Medicine, Stanford, California. Electronic address: paul.barnett@va.gov. 2. VA Health Economics Resource Center, Menlo Park, California; VA Center for Innovation to Implementation, Menlo Park, California. 3. New York Harbor VA Health Care System, New York, New York; Department of Population Health, New York University School of Medicine, New York, New York. 4. VA Center for Clinical Management Research, Ann Arbor, Michigan; College of Nursing, Ohio State University, Columbus, Ohio.
Abstract
INTRODUCTION: Electronic medical records represent a new source of longitudinal data on tobacco use. METHODS: Electronic medical records of the U.S. Department of Veterans Affairs were extracted to find patients' tobacco use status in 2009 and at another assessment 12-24 months later. Records from the year prior to the first assessment were used to determine patient demographics and comorbidities. These data were analyzed in 2015. RESULTS: An annual quit rate of 12.0% was observed in 754,504 current tobacco users. Adjusted tobacco use prevalence at follow-up was 3.2% greater with alcohol use disorders at baseline, 1.9% greater with drug use disorders, 3.3% greater with schizophrenia, and lower in patients with cancer, heart disease, and other medical conditions (all differences statistically significant with p<0.05). Annual relapse rates in 412,979 former tobacco users were 29.6% in those who had quit for <1 year, 9.7% in those who had quit for 1-7 years, and 1.9% of those who had quit for >7 years. Among those who had quit for <1 year, adjusted relapse rates were 4.3% greater with alcohol use disorders and 7.2% greater with drug use disorders (statistically significant with p<0.05). CONCLUSIONS: High annual cessation rates may reflect the older age and greater comorbidities of the cohort or the intensive cessation efforts of the U.S. Department of Veterans Affairs. The lower cessation and higher relapse rates in psychiatric and substance use disorders suggest that these groups will need intensive and sustained cessation efforts. Published by Elsevier Inc.
INTRODUCTION: Electronic medical records represent a new source of longitudinal data on tobacco use. METHODS: Electronic medical records of the U.S. Department of Veterans Affairs were extracted to find patients' tobacco use status in 2009 and at another assessment 12-24 months later. Records from the year prior to the first assessment were used to determine patient demographics and comorbidities. These data were analyzed in 2015. RESULTS: An annual quit rate of 12.0% was observed in 754,504 current tobacco users. Adjusted tobacco use prevalence at follow-up was 3.2% greater with alcohol use disorders at baseline, 1.9% greater with drug use disorders, 3.3% greater with schizophrenia, and lower in patients with cancer, heart disease, and other medical conditions (all differences statistically significant with p<0.05). Annual relapse rates in 412,979 former tobacco users were 29.6% in those who had quit for <1 year, 9.7% in those who had quit for 1-7 years, and 1.9% of those who had quit for >7 years. Among those who had quit for <1 year, adjusted relapse rates were 4.3% greater with alcohol use disorders and 7.2% greater with drug use disorders (statistically significant with p<0.05). CONCLUSIONS: High annual cessation rates may reflect the older age and greater comorbidities of the cohort or the intensive cessation efforts of the U.S. Department of Veterans Affairs. The lower cessation and higher relapse rates in psychiatric and substance use disorders suggest that these groups will need intensive and sustained cessation efforts. Published by Elsevier Inc.
Authors: David A Katz; Kenda R Stewart; Monica Paez; Mark W Vander Weg; Kathleen M Grant; Christine Hamlin; Gary Gaeth Journal: Patient Date: 2018-12 Impact factor: 3.883
Authors: Steffani R Bailey; Miguel Marino; David Ezekiel-Herrera; Teresa Schmidt; Heather Angier; Megan J Hoopes; Jennifer E DeVoe; John Heintzman; Nathalie Huguet Journal: Nicotine Tob Res Date: 2020-05-26 Impact factor: 4.244
Authors: Jaimee L Heffner; Scott Coggeshall; Chelle L Wheat; Paul Krebs; Laura C Feemster; Deborah E Klein; Linda Nici; Hannah Johnson; Steven B Zeliadt Journal: J Gen Intern Med Date: 2021-07-19 Impact factor: 6.473
Authors: Steffani R Bailey; Robert Voss; Heather Angier; Nathalie Huguet; Miguel Marino; Steele H Valenzuela; Katherine Chung-Bridges; Jennifer E DeVoe Journal: BMC Health Serv Res Date: 2022-04-12 Impact factor: 2.655
Authors: Anne C Melzer; Erika A Pinsker; Barbara Clothier; Siamak Noorbaloochi; Diana J Burgess; Elisheva R Danan; Steven S Fu Journal: BMC Med Res Methodol Date: 2018-05-11 Impact factor: 4.615